BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32856856)

  • 1. Surveillance of Esophageal Cancer in the Republic of Uzbekistan from 2000 to 2018.
    Yusupbekov A; Kanda M; Usmanov B; Tuychiev O; Baymakov S; Sakamoto J; Yusupbekov A
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2281-2285. PubMed ID: 32856856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in incidence and survival of esophageal cancer in Korea: Analysis of the Korea Central Cancer Registry Database.
    Shin A; Won YJ; Jung HK; Kong HJ; Jung KW; Oh CM; Choe S; Lee J
    J Gastroenterol Hepatol; 2018 Dec; 33(12):1961-1968. PubMed ID: 29802647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Descriptive analysis of esophageal cancer in Zambia using the cancer disease hospital database: young age, late stage at presentation.
    Asombang AW; Kasongo N; Muyutu J; Montiero JFG; Chishinga N; Chipaila J; Banda L
    Pan Afr Med J; 2021; 39():12. PubMed ID: 34394803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the incidence of esophageal adenocarcinoma increasing in Japan? Trends from the data of a hospital-based registration system in Akita Prefecture, Japan.
    Koizumi S; Motoyama S; Iijima K
    J Gastroenterol; 2018 Jul; 53(7):827-833. PubMed ID: 29134330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in treating oesophageal cancer.
    Harada K; Rogers JE; Iwatsuki M; Yamashita K; Baba H; Ajani JA
    F1000Res; 2020; 9():. PubMed ID: 33042518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis.
    He H; Chen N; Hou Y; Wang Z; Zhang Y; Zhang G; Fu J
    Thorac Cancer; 2020 May; 11(5):1121-1128. PubMed ID: 32154652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic evaluation of esophageal cancer patients with stages I-III.
    Qiu MJ; Yang SL; Wang MM; Li YN; Jiang X; Huang ZZ; Xiong ZF
    Aging (Albany NY); 2020 Jul; 12(14):14736-14753. PubMed ID: 32701062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global trends in esophageal cancer.
    Malhotra GK; Yanala U; Ravipati A; Follet M; Vijayakumar M; Are C
    J Surg Oncol; 2017 Apr; 115(5):564-579. PubMed ID: 28320055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary carbohydrate intake and the risk of esophageal cancer: a meta-analysis.
    Xuan F; Li W; Guo X; Liu C
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32027364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population-based study.
    Cattelan L; Ghazawi FM; Le M; Lagacé F; Savin E; Zubarev A; Gantchev J; Tomaszewski M; Sasseville D; Waschke K; Litvinov IV
    Cancer Med; 2020 Jan; 9(1):401-417. PubMed ID: 31715645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma.
    Kauppila JH; Wahlin K; Lagergren P; Lagergren J
    Int J Cancer; 2019 Mar; 144(6):1284-1291. PubMed ID: 30168595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West.
    Moaven O; Wang TN
    Surg Clin North Am; 2019 Jun; 99(3):479-499. PubMed ID: 31047037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.
    Njei B; McCarty TR; Birk JW
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1141-6. PubMed ID: 26749521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells in esophageal cancer and response to therapy.
    Harada K; Pool Pizzi M; Baba H; Shanbhag ND; Song S; Ajani JA
    Cancer; 2018 Oct; 124(20):3962-3964. PubMed ID: 30368777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant tumors of the esophagus in the Czech Republic].
    Duda M; Adamcík L; Dusek L; Skrovina M; Jínek T
    Rozhl Chir; 2012 Mar; 91(3):132-40. PubMed ID: 22881077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal adenocarcinoma incidence: are we reaching the peak?
    Pohl H; Sirovich B; Welch HG
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1468-70. PubMed ID: 20501776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostics and treatment of esophageal cancers].
    Verschuur EM; Siersema PD
    Ned Tijdschr Tandheelkd; 2010 Sep; 117(9):427-31. PubMed ID: 20968101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current malaria situation in the Republic of Uzbekistan].
    Razakov ShA; Shakhgunova GSh
    Med Parazitol (Mosk); 2001; (1):39-41. PubMed ID: 11548313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.
    Talukdar FR; di Pietro M; Secrier M; Moehler M; Goepfert K; Lima SSC; Pinto LFR; Hendricks D; Parker MI; Herceg Z
    Ann N Y Acad Sci; 2018 Dec; 1434(1):342-359. PubMed ID: 29917250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for lead-time and length-time biases in outcomes in esophageal adenocarcinoma.
    Rubenstein JH; Inadomi JM
    Am J Gastroenterol; 2009 Dec; 104(12):3106-7; author reply 3107-8. PubMed ID: 19956133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.